582 related articles for article (PubMed ID: 4834485)
1. Activated prothrombin concentrate for patients with factor VIII inhibitors.
Kurczynski EM; Penner JA
N Engl J Med; 1974 Jul; 291(4):164-7. PubMed ID: 4834485
[No Abstract] [Full Text] [Related]
2. Editorial: Factor VIII inhibitors.
Deykin D
N Engl J Med; 1974 Jul; 291(4):205. PubMed ID: 4834491
[No Abstract] [Full Text] [Related]
3. Surgical care of patients with hereditary disorders of blood coagulation.
Shulman NR
Mod Treat; 1968 Jan; 5(1):61-83. PubMed ID: 4870180
[No Abstract] [Full Text] [Related]
4. Treatment of hemophilia B with a new clotting-factor concentrate.
Hoag MS; Johnson FF; Robinson JA; Aggeler PM
N Engl J Med; 1969 Mar; 280(11):581-6. PubMed ID: 5764825
[No Abstract] [Full Text] [Related]
5. Therapeutic materials used in the treatment of coagulation defects.
Smith JK; Bidwell E
Clin Haematol; 1979 Feb; 8(1):183-206. PubMed ID: 367662
[No Abstract] [Full Text] [Related]
6. Therapeutic approaches to factor X deficiency with emphasis on the use of a new clotting-factor concentrate (Konyne).
O'Leary DS; Ruymann FB; Conrad ME
J Lab Clin Med; 1971 Jan; 77(1):23-32. PubMed ID: 5540427
[No Abstract] [Full Text] [Related]
7. [Clinical experience with the PPSB fraction in surgery].
Frick U
Zentralbl Chir; 1972 Feb; 97(5):150-3. PubMed ID: 5020589
[No Abstract] [Full Text] [Related]
8. Prothrombin complex concentrate (Konyne) in the treatment of hemophilic patients with factor VIII inhibitors.
Abildgaard CF; Britton M; Harrison J
J Pediatr; 1976 Feb; 88(2):200-5. PubMed ID: 1249680
[TBL] [Abstract][Full Text] [Related]
9. Use of prothrombin complex concentrates in hemophiliacs with inhibitors: clinical and laboratory studies.
Buchanan GR; Kevy SV
Pediatrics; 1978 Nov; 62(5):767-74. PubMed ID: 724319
[TBL] [Abstract][Full Text] [Related]
10. [6-years' experience with the clinical use of the hemostatic preparation, PPSB].
Koniukhov SG; Saltykova ZA; Tarasova LN
Probl Gematol Pereliv Krovi; 1977 Aug; 22(8):37-40. PubMed ID: 928338
[No Abstract] [Full Text] [Related]
11. Coagulation defects in acute promyelocytic leukemia.
Rand JJ; Moloney WD; Sise HS
Arch Intern Med; 1969 Jan; 123(1):39-47. PubMed ID: 5248747
[No Abstract] [Full Text] [Related]
12. [Administration of a new prothrombin complex concentrate in patients treated with anticoagulants and in patients with liver diseases].
Fischer M; Falkensammer C; Gauss P; Korp W; Kubiena K; Neubert J; Schnack H; Weissmann A
Med Welt; 1973 Nov; 24(48):1899-902. PubMed ID: 4774863
[No Abstract] [Full Text] [Related]
13. Clinical use of human prothrombin complexes.
Tullis JL; Melin M; Jurigian P
N Engl J Med; 1965 Sep; 273(13):667-74. PubMed ID: 5827030
[No Abstract] [Full Text] [Related]
14. Coagulation changes during massive hepatic necrosis due to Amanita phalloides poisoning with special reference to antihemophilic globulin.
Meili EO; Frick PG; Straub PW
Helv Med Acta; 1970 Oct; 35(4):304-13. PubMed ID: 5507041
[No Abstract] [Full Text] [Related]
15. Blood coagulation values of sheep.
Gajewski J; Povar ML
Am J Vet Res; 1971 Mar; 32(3):405-9. PubMed ID: 5547008
[No Abstract] [Full Text] [Related]
16. [On the therapy of bleeding tendency due to vitamin K deficiency and dysfunction of the liver during the first year of life. (Combined treatment with a concentrate of factors II, VII, IX and X and heparin) (author's transl)].
Göbel U; Petrich C
Monatsschr Kinderheilkd (1902); 1974 Feb; 122(2):60-4. PubMed ID: 4594807
[No Abstract] [Full Text] [Related]
17. Human prothrombin complex.
N Engl J Med; 1965 Sep; 273(13):715-6. PubMed ID: 5827038
[No Abstract] [Full Text] [Related]
18. Treatment of hemophilia complicated by inhibitors.
Scand J Haematol Suppl; 1980; 35():135-64. PubMed ID: 6770458
[No Abstract] [Full Text] [Related]
19. Induction of immune tolerance in hemophiliacs with inhibitors by combined treatment with i.v. IgG, cyclophosphamide and factor VIII or IX.
Nilsson IM; Berntorp E
Prog Clin Biol Res; 1990; 324():69-78. PubMed ID: 2106694
[No Abstract] [Full Text] [Related]
20. Letter: Treatment of inhibitors to factor VIII with activated prothrombin concentrate.
Sultan Y; Brouet JC; Debre P
N Engl J Med; 1974 Nov; 291(20):1087. PubMed ID: 4414451
[No Abstract] [Full Text] [Related]
[Next] [New Search]
